Interferon β for relapsing-remitting MS: Tolerance, therapy adherence and quality of life in the first 3 months of treatment

2009 
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []